The LL۳۷-rIb-AMP۴ antimicrobial peptide as a treatment for systematic infection of Pseudomonas aeruginosa, Acinetobacter baumannii, Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococci (VRE) cells in a mouse model.

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 182

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IEM-9-4_007

تاریخ نمایه سازی: 30 بهمن 1402

چکیده مقاله:

Aims: Antimicrobial peptides (AMPs) are beneficial compounds that could be used as a new and effective method to suppress microbes. Both Ib-AMP۴ and LL۳۷ are antimicrobial peptides with a wide range of antimicrobial activities. This research aimed to evaluate the antibacterial potential of LL۳۷-rIb-AMP۴ hybrid protein as an antimicrobial agent against pathogenic bacteria. Therefore, its antibacterial effects against Acinetobacter baumannii, Pseudomonas aeruginosa, vancomycin-resistant Enterococcus (VRE), and methicillin-resistant Staphylococcus aureus (MRSA) were investigated in vivo and in vitro. Materials & Methods: In this study, antimicrobial peptides rIb-AMP۴, LL۳۷, and LL۳۷-rIb-AMP۴ were expressed, purified, and refolded, and their synergistic and antibacterial effects in combination with each other (LL۳۷+rIb-AMP۴) and as fusion proteins (LL۳۷-rIb-AMP۴) were tested against A. baumannii, P. aeruginosa, VRE, and MRSA cells in vitro (MIC, time kill, and SEM) and against P. aeruginosa and VRE cells in vivo. Findings: LL۳۷-rIb-AMP۴ Protein with molecular weight= ۲۸ KD was correctly produced and purified. Despite the lack of synergistic effects between LL۳۷ and rIb-AMP۴ peptides in vitro, the stability test results showed higher stability for LL۳۷-rIb-AMP۴ hybrid protein. The findings of in vivo tests confirmed that all infected mice were improved with LL۳۷-rIb-AMP۴ and no signs of bacteria were observed in their blood and spleen samples. Also, these results confirmed the stability and higher activity of LL۳۷-rIb-AMP۴ than the single form of these proteins. Conclusion: Considering the antimicrobial potential of the produced proteins, it seems that the recombinant LL۳۷-rIb-AMP۴ protein could be considered and used as a stable and active antimicrobial drug in future studies.

نویسندگان

Ehsanollah Ghaznavi-Rad

Molecular and Medical Research Center, Arak University of Medical Sciences, Arak, Iran.

Ali Sadoogh Abbasian۲

Department of Internal Medicine, School of Medicine, Amiralmomenin Hospital, Arak University of Medical Sciences, Arak, Iran.

shabnam Sadoogh Abbasian

Molecular and Medical Research Center, Arak University of Medical Sciences, Arak, Iran.

Ehsan Zarei-Mehrvarz

Molecular and Medical Research Center, Arak University of Medical Sciences, Arak, Iran.

Hamid Abtahi

Molecular and Medical Research Center, Arak University of Medical Sciences, Arak, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Xuan J, Feng W, Wang J, et al. Antimicrobial peptides ...
  • Stefanucci A, Mosquera J, Vázquez E, Mascareñas JL, Novellino E, ...
  • Xhindoli D, Pacor S, Benincasa M, Scocchi M, Gennaro R, ...
  • Flórez-Castillo JM, Ropero-Vega JL, Perullini M, & Jobbágy M. Biopolymeric ...
  • Huan Y, Kong Q, Mou H, Yi H. Antimicrobial Peptides: ...
  • Sadoogh Abbasian S, Ghaznavi-Rad E, Akbari N, Zolfaghari MR, Pakzad ...
  • Sadoogh Abbasian S, Soufian S, Ghaznavi-Rad E, Abtahi H. High ...
  • Mahmoudi S, Abtahi H, Bahador A, Mosayebi G, Salmanian AH. ...
  • Farjadi V, Abtahi H, Zolfaghari M R, Soufian S, Hasanzadeh ...
  • Fahimirad S, Razavi SH, Abtahi H, Alizadeh H, Ghorbanpour M. ...
  • Sadoogh Abbasian S, Abtahi H, Zolfaghari MR, Soufian S and ...
  • Didevara E, Sadoogh Abbasian S, Sadeghi A, Abtahi H. Production ...
  • Mirjamali NA, Soufian S, Molaee N, Abbasian SS, Abtahi H. ...
  • Khaki M, Ganji A, Abtahi H, Mosayebi G, Baazm M, ...
  • Clinical and Laboratory Standards Institute. M۰۷-A۱۰: Methods for dilution antimicrobial ...
  • Fahimirad S, Abtahi H, Razavi SH, Alizadeh H, Ghorbanpour M. ...
  • Zarei-Mehrvarz E, Fahimirad S, Ghaznavi-Rad E, Abbasian SS, Abtahi H. ...
  • Fahimirad S, Ghaznavi-Rad E, Abtahi H, Sarlak N. Antimicrobial activity, ...
  • Wang M, Liang C, Hu H, Zhou L, Xu B, ...
  • Mancuso G, Midiri A, Gerace E, Biondo C. Bacterial Antibiotic ...
  • Mba IE, Nweze EI. Antimicrobial Peptides Therapy: An Emerging Alternative ...
  • Mukhopadhyay S, Bharath Prasad AS, Mehta CH, Nayak UY. Antimicrobial ...
  • Sadelaji S, Ghaznavi-Rad E, Sadoogh Abbasian S, Fahimirad S, Abtahi ...
  • Fan X, Reichling J, Wink M. Antibacterial activity of the ...
  • Fan X, Schäfer H, Reichling J, Wink M. Bactericidal properties ...
  • Turner J, Cho Y, Dinh NN, Waring AJ, Lehrer RI. ...
  • Sun Y, Shang D. Inhibitory Effects of Antimicrobial Peptides on ...
  • نمایش کامل مراجع